Teva Wins FDA Approval for Monthly Schizophrenia Injection
Weltruza replaces daily pills with once-monthly injections for patients with schizophrenia, potentially becoming a major revenue source for Teva.
On air: Hank Ledger on BBN This MorningPublished
The real story
The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.
- CNBCTeva wins FDA approval for monthly schizophrenia injection Weltruza
“Thank you, Skip. It is not. Teva is up in premarket on the FDA nod. Go dry off.”
More in U.S.
All U.S. →
U.S.
Trump's Revenge Campaign Hits Turmoil, NYT Reports
Trump allies tried to prove a grand conspiracy through a Justice Department inquiry, but it collapsed amid staffing shake-ups, internal disputes…
U.S.
Panama Quake, Dubai Crash Probe, Ditka Remembered
The FlyDubai co-pilot allegedly intended to crash into an Israeli airport after years of developing extreme Islamist views inspired by September…
PILE-ON
ICC President Vows to Keep Working Despite New U.S. Sanctions
ICC President Tomoko Akane said Friday the court will continue its investigations involving the United States and Israel despite the new sanctions…